CIITA and neoplasm: These results represent the first evidence that a protective adaptive immune response against the most deadly tumor of the CNS may be generated in vivo by inducing the tumor cells to express CIITA and thus their own MHC class II molecules that may serve, as demonstrated previously in other tumor models, to present their own tumor antigens.